103 related articles for article (PubMed ID: 3136600)
1. [Cyclosporin A in chronic active hepatitis. Results of a pilot study of 20 patients].
Friedrich K; Henning H
Z Gastroenterol; 1988 May; 26(5):265-70. PubMed ID: 3136600
[TBL] [Abstract][Full Text] [Related]
2. [Interferon therapy in chronic active viral hepatitis].
Lengyel G; Fehér J
Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
[TBL] [Abstract][Full Text] [Related]
3. [Antiviral treatment of chronic hepatitis].
Müller R
Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
[No Abstract] [Full Text] [Related]
4. Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients.
Akbar N; Tahir RA; Santoso WD; Soemarno ; Sumaryono ; Noer HM; Liu G
Chin Med J (Engl); 1998 Mar; 111(3):248-51. PubMed ID: 10374427
[TBL] [Abstract][Full Text] [Related]
5. Interferons in the management of viral hepatitis.
Zein NN
Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
[TBL] [Abstract][Full Text] [Related]
6. [Ursodeoxycholic hemisuccinate in the treatment of chronic active hepatitis. A controlled clinico-therapeutic study].
Buzzelli G; Moscarella S; Focardi G; Dattolo P; Giusti A; Calviani L; Relli P; Gentilini P
Minerva Med; 1992 Sep; 83(9):537-40. PubMed ID: 1436604
[TBL] [Abstract][Full Text] [Related]
7. [Chronic hepatitis: current diagnostics and treatment in different etiologic factors].
Glaumann H; Lööf L; Weiland O
Lakartidningen; 1991 Mar; 88(13):1201-4. PubMed ID: 1901930
[No Abstract] [Full Text] [Related]
8. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
[TBL] [Abstract][Full Text] [Related]
9. [Long-term prognosis of chronic B and C viral hepatitis].
Ohlen J; Liegl JM; Selmair H
Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative and morphometric investigations on the histopathology of chronic hepatitis non-A, non-B.
Volmer J; Lüders CJ; Henning H
Z Gastroenterol; 1985 Nov; 23(11):632-42. PubMed ID: 3937345
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Tanno H; Fay O; Roldán L; Vorovioff J
Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
[TBL] [Abstract][Full Text] [Related]
13. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.
Pramoolsinsap C; Sirikulchayanonta V; Busakorn W; Poovorawan Y; Hirsch P; Theamboonlers A; Lerdverasirikul P
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):741-9. PubMed ID: 10928369
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
Ohlen I; Liegl JM; Selmair H
Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
[TBL] [Abstract][Full Text] [Related]
16. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
[TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of therapeutic effect of catergen in viral hepatitis].
Boroń P; Boroń-Kaczmarska A; Sokolewicz-Bobrowska E; Szpakowicz T; Nadowska K
Pol Tyg Lek; 1979 Aug; 34(33):1315-7. PubMed ID: 117435
[No Abstract] [Full Text] [Related]
20. Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Bertolino F; Ferreli A
Helv Paediatr Acta; 1983 Aug; 38(3):255-65. PubMed ID: 6618892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
